# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY TEMPLATE

A. 510(k) Number: k151982   
B. Purpose for Submission: Modification of a previously cleared device (k142220) – modify the intended use of the device to include Point-of-Care use   
C. Measurand: pH, PCO2, and PO2   
D. Type of Test: Quantitative: Traditional electrode technology to measure blood PO2; Ion selective electrode technology to measure blood pH, PCO2.   
E. Applicant: Nova Biomedical Corporation   
F. Proprietary and Established Names: Stat Profile Prime ABG Analyzer System   
G. Regulatory Information:

<table><tr><td rowspan=1 colspan=1>ProductCode</td><td rowspan=1 colspan=1>Classification</td><td rowspan=1 colspan=1>Regulation Section</td><td rowspan=1 colspan=1>Panel</td></tr><tr><td rowspan=1 colspan=1>CHL</td><td rowspan=1 colspan=1>II</td><td rowspan=1 colspan=1>862.1120, Blood Gases (pCO2, pO2)and Blood pH system</td><td rowspan=1 colspan=1>75-Chemistry</td></tr></table>

# H. Intended Use:

1. Intended use(s): See indications for use below.

2. Indication(s) for use:

The Stat Profile Prime ABG Analyzer System is intended for in vitro diagnostic use by health care professionals in clinical laboratory settings and for point-of-care usage for the quantitative determination of pH, PCO2, and PO2 in heparinized whole blood.

PCO2, PO2, pH: Whole blood measurement of certain gases in whole blood, or pH of whole blood, is used in the diagnosis and treatment of life‐threatening acid‐base disturbances.

3. Special conditions for use statement(s): For prescription use only. For clinical laboratory and point-of-care use.

4. Special instrument requirements: Stat Profile Prime ABG Analyzer System.

# I. Device Description:

The Stat Profile Prime ABG Analyzer is a small blood gas analyzer for laboratory and pointof-care use. The sensors and flow path have been integrated into one replaceable microsensor card, which is replaced periodically according to usage. The product, consumables, installation instructions and packaging are designed for easy customer installation. Whole blood specimens are aspirated into the analyzer’s micro-sensor card from syringes, tubes, or capillary blood collection devices using a peristaltic pump and a sampling probe. The disposable micro-sensor card contains the analytical flow-path and all of the measurement sensors (pH, PCO2, PO2). Once the analysis measurement is complete, the whole blood specimen is automatically flushed out of the micro-sensor card flow-path and into a selfcontained waste collection bag contained within the disposable calibrator cartridge.

The Stat Profile Prime ABG Analyzer has multiple quality control options. Both traditional internal and external liquid QC will be available, as well as an onboard Quality Management System (QMS). The Stat Profile Prime ABG Analyzer has two primary sample modes: syringe and capillary modes. The minimum sample size for both analysis modes is $5 0 \mu \mathrm { L }$ .

# J. Substantial Equivalence Information:

1. Predicate device name(s): Stat Profile Prime ABG Analyzer   
2. Predicate 510(k) number(s): k142220   
3. Comparison with predicate:

<table><tr><td rowspan=1 colspan=4>Similarities and Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=2>Predicate Device: Stat ProfilePrime ABG Analyzer(k142220)</td><td rowspan=1 colspan=1>Candidate Device:Stat Profile Prime ABGAnalyzer(k151982)</td></tr><tr><td rowspan=1 colspan=1>Intended use</td><td rowspan=1 colspan=2>For in vitro diagnostics use forthe determination of pH, PO2,and PCO2 in heparinizedwhole blood by health careprofessionals</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Configuration</td><td rowspan=1 colspan=2>2 level calibration standardsper analyte, and referencesolution</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Packaging</td><td rowspan=1 colspan=2>Liquid in Mylar bags insidecardboard container. Includesa waste collection bag. Self-contained, disposablepackaging.</td><td rowspan=1 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>Settings for use</td><td rowspan=1 colspan=2>Clinical laboratories</td><td rowspan=1 colspan=1>Clinical laboratories andpoint-of-care settings.</td></tr><tr><td rowspan=3 colspan=1>Measuring range</td><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>6.500-8.000</td><td rowspan=3 colspan=1>Same</td></tr><tr><td rowspan=1 colspan=1>PCO2</td><td rowspan=1 colspan=1>3.0-200 mmHg</td></tr><tr><td rowspan=1 colspan=1>PO2</td><td rowspan=1 colspan=1>5-765 mmHg</td></tr></table>

# K. Standard/Guidance Document Referenced (if applicable):

CLSI EP05-A2, Evaluation of Precision Performance of Quantitative Measurement Methods; Approved Guideline-Second Edition

CLSI EP09-A2, Method Comparison and Bias Estimation Using Patient Samples; Approved Guideline-Second Edition

# L. Test Principle:

pH is measured using a hydrogen ion selective membrane. One side of the membrane is in contact with a solution of constant pH. The other side is in contact with a solution of unknown pH. A change in potential develops which is proportional to the pH difference of these solutions. This change in potential is measured against a reference electrode of constant potential.

PCO2 is measured with a modified pH sensor. Carbon dioxide in the unknown solution makes contact with a hydrogen ion selective membrane CO2 diffuses across the membrane into a thin layer of bicarbonate buffer in response to partial pressure difference. This solution then becomes equilibrated with the external gas pressure of the fluid in contact with the outer surface of the membrane. CO2 in the solution becomes hydrated producing carbonic acid

which results in a change in hydrogen ion activity. The measured potential is related to the logarithm of $P \mathrm { C O 2 }$ content of the sample after compensation of the measured potential of the pH sensor.

PO2 is measured amperometrically by the generation of a current at the sensor surface. As oxygen diffuses through a gas permeable membrane, the oxygen molecules are reduced at the cathode, consuming 4 electrons for every molecule of oxygen reduced. This flow of electrons is then measured by the sensor and is directly proportional to the partial pressure of oxygen.

# M. Performance Characteristics (if/when applicable):

1. Analytical performance:

a. Precision/Reproducibility:

The within run precision study was performed at three point-of-care (POC) sites, including a cardiovascular intensive care unit (CVICU), a medical intensive care unit (MICU) and a pulmonary care unit (PCU) by a total of 52 POC personnel, comprised of 35 respiratory therapy and 17 nursing POC personnel. The study was performed by analyzing 20 replicates of 3 levels of Stat Profile Prime External Quality Control material (levels 1-3) on a Stat Profile Prime ABG analyzer at each POC site. All three sites produced similar results. Representative within run precision results are summarized in tables below:

One representative POC (site 1): Within Run Precision with Controls $\mathrm { ( N } { = } 2 0$ )   

<table><tr><td rowspan=1 colspan=4>Within Run Precision - Level 1</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Mean</td><td rowspan=1 colspan=1>SD</td><td rowspan=1 colspan=1>CV%</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.154</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>0.04</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>59.5</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>0.8</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>62.3</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>2.9</td></tr><tr><td rowspan=1 colspan=4>Within Run Precision - Level 2</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.368</td><td rowspan=1 colspan=1>0.002</td><td rowspan=1 colspan=1>0.03</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>41.6</td><td rowspan=1 colspan=1>0.5</td><td rowspan=1 colspan=1>1.2</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>97.6</td><td rowspan=1 colspan=1>1.9</td><td rowspan=1 colspan=1>2.0</td></tr><tr><td rowspan=1 colspan=4>Within RunPrecision - Level 3</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.568</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>0.04</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>24.3</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.6</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>136.6</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>2.3</td></tr></table>

A total imprecision study was performed at different point-of-care (POC) sites by different POC personnel by analyzing 3 levels of Stat Profile Prime External Quality Control material (levels 1-3) in duplicate for 20 days for a total of 40 measurements on each of three Stat Profile Prime ABG Analyzers. All three sites produced similar results. The total imprecision data from one representative POC site is shown in the table below:

Total Imprecision from one representative POC Site $\scriptstyle ( \mathrm { N } = 4 0 )$   

<table><tr><td rowspan=1 colspan=6>Total Imprecision Data - Level 1</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>PooledMean</td><td rowspan=1 colspan=1>WithinRunSD</td><td rowspan=1 colspan=1>Within Run%CV</td><td rowspan=1 colspan=1>TotalSD</td><td rowspan=1 colspan=1>Total%CV</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.150</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>0.041</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>0.049</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>60.7</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>1.1</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>61.7</td><td rowspan=1 colspan=1>1.8</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>2.9</td><td rowspan=1 colspan=1>4.7</td></tr><tr><td rowspan=1 colspan=6>TotalImprecision Data - Level 2</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.366</td><td rowspan=1 colspan=1>0.001</td><td rowspan=1 colspan=1>0.020</td><td rowspan=1 colspan=1>0.004</td><td rowspan=1 colspan=1>0.049</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>41.4</td><td rowspan=1 colspan=1>0.3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.8</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>99.5</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>2.3</td><td rowspan=1 colspan=1>2.3</td></tr><tr><td rowspan=1 colspan=6>TotalImprecision Data - Level 3</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.561</td><td rowspan=1 colspan=1>0.005</td><td rowspan=1 colspan=1>0.072</td><td rowspan=1 colspan=1>0.008</td><td rowspan=1 colspan=1>0.100</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>25.5</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>2.4</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>4.9</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>137.6</td><td rowspan=1 colspan=1>2.0</td><td rowspan=1 colspan=1>1.5</td><td rowspan=1 colspan=1>3.3</td><td rowspan=1 colspan=1>2.4</td></tr></table>

The combined-site total imprecision results from all 3 sites are summarized in the tables below:

Total impression with external quality control materials $\scriptstyle ( \mathrm { N } = 1 2 0 )$   

<table><tr><td rowspan=1 colspan=6>Combined Total Imprecision Data - Level 1</td></tr><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>PooledMean</td><td rowspan=1 colspan=1>WithinRunSD</td><td rowspan=1 colspan=1>Within Run%CV</td><td rowspan=1 colspan=1>TotalSD</td><td rowspan=1 colspan=1>Total%CV</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.152</td><td rowspan=1 colspan=1>0.004</td><td rowspan=1 colspan=1>0.056</td><td rowspan=1 colspan=1>0.005</td><td rowspan=1 colspan=1>0.070</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>61.3</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>1.3</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>2.7</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>64.0</td><td rowspan=1 colspan=1>1.6</td><td rowspan=1 colspan=1>2.5</td><td rowspan=1 colspan=1>3.2</td><td rowspan=1 colspan=1>5.0</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=5>Combined Total Imprecision Data - Level 2</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.367</td><td rowspan=1 colspan=1>0.002</td><td rowspan=1 colspan=1>0.027</td><td rowspan=1 colspan=1>0.003</td><td rowspan=1 colspan=1>0.041</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>41.1</td><td rowspan=1 colspan=1>0.4</td><td rowspan=1 colspan=1>1.0</td><td rowspan=1 colspan=1>0.6</td><td rowspan=1 colspan=1>1.5</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>101.7</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>1.4</td><td rowspan=1 colspan=1>3.0</td><td rowspan=1 colspan=1>2.9</td></tr><tr><td rowspan=1 colspan=1></td><td rowspan=1 colspan=4>Combined Total Imprecision Data - Level 3</td><td rowspan=1 colspan=1></td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>7.560</td><td rowspan=1 colspan=1>0.006</td><td rowspan=1 colspan=1>0.079</td><td rowspan=1 colspan=1>0.007</td><td rowspan=1 colspan=1>0.093</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>25.5</td><td rowspan=1 colspan=1>0.8</td><td rowspan=1 colspan=1>3.1</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>4.7</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>139.8</td><td rowspan=1 colspan=1>1.7</td><td rowspan=1 colspan=1>1.2</td><td rowspan=1 colspan=1>4.0</td><td rowspan=1 colspan=1>2.8</td></tr></table>

$b$ . Linearity/assay reportable range:

The linearity study has been previously reviewed in k142220.

c. Traceability, Stability, Expected values (controls, calibrators, or methods):

The traceability of the $\mathrm { p H }$ standards and reagents, and the traceability of the PCO2/PO2 controls and reagents have been previously reviewed in k142220.

The stability and value assignment for the calibrators, internal and external controls have been previously reviewed in k142220.

d. Detection limit: The detection limit study has been previously reviewed in k142220.   
e. Analytical specificity: The analytical specificity study has been previously reviewed in k142220.   
f. Assay cut-off: Not applicable.

2. Comparison studies:

# a. Method comparison with predicate device:

Method comparison study for all analytes was previously cleared in k142220 for clinical laboratory use only. In order to add Point-of-Care claim, sponsor has conducted POC study using the intended POC operators at the intended use sites to demonstrate that POC operators could generate equivalent results as the clinical laboratory professionals. A method comparison study was performed at 3 POC sites by a total of 52 different POC personnel (35 respiratory therapist and 17 nurses) using the analyzer’s syringe mode method. Approximately 188 Lithium heparin whole blood gas specimens from syringes were analyzed to compare the whole blood results obtained by trained laboratory personnel vs respiratory therapy POC personnel on the same specimens. No more than $1 2 . 7 \%$ of samples for each analyte were altered in order to adequately span the measuring range. Each of the three sites produced similar method comparison data. Syringe mode method comparison study data is shown below from one representative POC site and the three combined POC sites:

Syringe Mode: POC vs. Laboratory Professionals, one representative POC site   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Whole BloodRange tested</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>6.897-7.726</td><td rowspan=1 colspan=1>1.001</td><td rowspan=1 colspan=1>-0.012</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>4.3-193.0</td><td rowspan=1 colspan=1>0.996</td><td rowspan=1 colspan=1>1.023</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>62</td><td rowspan=1 colspan=1>11.8-700.1</td><td rowspan=1 colspan=1>0.987</td><td rowspan=1 colspan=1>0.843</td><td rowspan=1 colspan=1>1.000</td></tr></table>

Syringe Mode: Combined all 3 POC sites   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1>Whole BloodRange tested</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>188</td><td rowspan=1 colspan=1>6.785-7.767</td><td rowspan=1 colspan=1>0.997</td><td rowspan=1 colspan=1>0.018</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>188</td><td rowspan=1 colspan=1>4.3-193.0</td><td rowspan=1 colspan=1>1.001</td><td rowspan=1 colspan=1>1.063</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>188</td><td rowspan=1 colspan=1>11.8-755.3</td><td rowspan=1 colspan=1>1.015</td><td rowspan=1 colspan=1>-0.939</td><td rowspan=1 colspan=1>1.000</td></tr></table>

Another method comparison study was performed at 3 POC sites by a total of 52 different POC personnel (35 respiratory therapists and 17 nurses) using the analyzer’s capillary mode method. Approximately 127 heparinized blood gas specimens from capillary tubes were run to compare the whole blood results obtained by trained laboratory personnel vs POC personnel on the same specimens. No more than $9 . 5 \%$ of samples for each analyte were altered in order to adequately span the measuring range. Each of the three sites produced similar method comparison data. The capillary mode method comparison study data from one representative POC site and data from the three combined POC sites is shown in the tables below:

Capillary Mode: POC vs Laboratory Professionals, one representative POC site   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Whole BloodRange tested</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>6.903-7.737</td><td rowspan=1 colspan=1>1.005</td><td rowspan=1 colspan=1>-0.035</td><td rowspan=1 colspan=1>0.999</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>3.2-182.5</td><td rowspan=1 colspan=1>0.989</td><td rowspan=1 colspan=1>1.21</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>43</td><td rowspan=1 colspan=1>16.2-649.9</td><td rowspan=1 colspan=1>1.037</td><td rowspan=1 colspan=1>-1.553</td><td rowspan=1 colspan=1>1.000</td></tr></table>

Capillary Mode: Combined all 3 POC sites   

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>n</td><td rowspan=1 colspan=1>Whole BloodRange tested</td><td rowspan=1 colspan=1>Slope</td><td rowspan=1 colspan=1>Intercept</td><td rowspan=1 colspan=1>r</td></tr><tr><td rowspan=1 colspan=1>pH</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>6.791-7.737</td><td rowspan=1 colspan=1>0.993</td><td rowspan=1 colspan=1>0.047</td><td rowspan=1 colspan=1>0.998</td></tr><tr><td rowspan=1 colspan=1>PCO2 (mmHg)</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>3.2-192.2</td><td rowspan=1 colspan=1>0.984</td><td rowspan=1 colspan=1>1.347</td><td rowspan=1 colspan=1>0.997</td></tr><tr><td rowspan=1 colspan=1>PO2 (mmHg)</td><td rowspan=1 colspan=1>127</td><td rowspan=1 colspan=1>13.1-672.9</td><td rowspan=1 colspan=1>1.041</td><td rowspan=1 colspan=1>-2.761</td><td rowspan=1 colspan=1>0.999</td></tr></table>

b. Matrix comparison: Not applicable.

3. Clinical studies:

a. Clinical Sensitivity: Not applicable.   
b. Clinical specificity: Not applicable.   
c. Other clinical supportive data (when a. and b. are not applicable): Not applicable.

4. Clinical cut-off: Not applicable.

5. Expected values/Reference range:

<table><tr><td rowspan=1 colspan=1>Parameter</td><td rowspan=1 colspan=1>Reference Range</td></tr><tr><td rowspan=1 colspan=1>pH1,2,3</td><td rowspan=1 colspan=1>7.35-7.45</td></tr><tr><td rowspan=1 colspan=1>PCO21,2,3</td><td rowspan=1 colspan=1>35-45 mmHg</td></tr><tr><td rowspan=1 colspan=1>PO21,2,3</td><td rowspan=1 colspan=1>83-108 mmHg</td></tr></table>

References:

1. Statland, Bernard. 1987. Clinical Decisions Levels for Lab Tests, Medical Economics Books.   
2. Burtis, Carl A. and Ashwood, Edward R., ed. 1994. Tietz Textbook of Clinical Chemistry. Philadelphia, PA: W. B. Saunders Co.   
3. Burtis, Carl A. Ashwood, Edward R., Burns, David R., 2011. Tietz Textbook of Clinical Chemistry and Molecular Diagnostics. ${ 5 } ^ { t h }$ ed, Philadelphia, PA: W. B. Saunders Co.

# N. Proposed Labeling:

The labeling is sufficient and it satisfies the requirements of 21 CFR Part 809.10, and 21 CFR Part 801.109(b)(1) to indicate For In Vitro Diagnostic Use and Prescription Use Only.

# O. Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.